Amikacin: a rapid and sensitive radioimmunoassay

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Amikacin is a crucial semisynthetic aminoglycoside antibiotic.
• Accurate measurement of amikacin levels is essential for effective therapeutic drug monitoring.
• Existing methods may lack the speed or sensitivity required for clinical settings.

Purpose of the Study:

• To develop a rapid, sensitive, and specific radioimmunoassay for amikacin.
• To validate the assay's performance in various biological matrices.
• To assess the assay's utility for timely clinical determinations.

Main Methods:

• Production of amikacin-specific antisera in rabbits using amikacin-thyroglobulin conjugate.
• Screening of antisera using tritium-labeled amikacin.
• Separation of bound and free radioactivity via a second antibody method.
• Validation of assay performance across different pH, ionic strength, and interfering substance concentrations.

Main Results:

• The radioimmunoassay demonstrates high sensitivity, measuring as little as 5 ng/mL of amikacin in serum, CSF, and urine.
• The assay is robust, with standard curves unaffected by variations in pH, ionic strength, divalent cations, or urea.
• Antibodies exhibit cross-reactivity with kanamycin but minimal cross-reactivity (<0.1%) with other tested antibiotics.
• A 30-minute incubation period is feasible due to co-incubation of antibodies, enabling stat determinations.
• Logit-log plotting allows for efficient computer-aided analysis and quality control.

Conclusions:

• A validated radioimmunoassay provides a rapid and sensitive method for amikacin quantification.
• The assay's robustness and speed make it suitable for routine clinical use and emergency testing.
• This assay facilitates precise therapeutic drug monitoring, optimizing amikacin treatment outcomes.